# Zempi Strategic Roadmap
*Last Updated: October 2025*

---

## üéØ CORE VALUE PROPOSITION

### The One-Liner
**"Don't just lose weight. Keep it off."**

### The Full Positioning
**Zempi turns temporary GLP-1 results into permanent transformations.**

Daily clinical coaching via WhatsApp that builds the muscle, habits, and metabolic foundation NOW ‚Äî while your GLP-1 is working ‚Äî so when you stop (by choice or necessity), your results don't disappear.

### Portuguese Version
**"O seguro contra o efeito rebote dos GLP-1s."**

Build the muscle, habits, and metabolic foundation NOW ‚Äî while your GLP-1 is working ‚Äî so when you stop (by choice or necessity), your results don't disappear. Clinical daily coaching via WhatsApp that turns temporary medication into permanent transformation.

---

## üî• THE BRUTAL TRUTH: Why This Matters

### The Industry's Dirty Secret
- **70% of people stop GLP-1s within 1 year**
- **65% regain the weight within 1 year after stopping**
- **Cost crisis**: $1,000/month, 51% have NO insurance coverage
- **User testimony**: "I'm terrified to get off them"

### The Core Insight
**GLP-1s are training wheels for weight loss.** They work WHILE you're on them. But 70% of people never learn to ride the bike. When the medication stops (due to cost, side effects, or choice), they crash.

**Current market says**: "We'll help you optimize your ride while the training wheels are on"

**Zempi says**: "We'll teach you to ride so you never need the training wheels again"

---

## üìä THE REAL PROBLEMS (Ranked by User Impact)

### 1. WEIGHT REGAIN TERROR (The Existential Fear)
- 70% discontinuation rate within 1 year
- 65% regain weight within 1 year after stopping
- Users report being "terrified to get off them"
- **This is the #1 psychological burden**
- **This is what we solve**

### 2. MUSCLE LOSS CRISIS
- 25-40% of total weight lost is lean muscle mass
- Critical for long-term metabolism preservation
- Users aren't educated until too late
- Requires: 0.5-0.9g protein/lb body weight + resistance training
- **Prevention must start DAY ONE of medication**

### 3. INADEQUATE MEDICAL SUPPORT GAP
- 29% feel "under-supported" in first 30 days
- 81% want personalized, prescriber-led care
- Doctors don't have time for daily/weekly guidance
- Healthcare system not designed for chronic medication management
- **WhatsApp fills this gap perfectly**

### 4. COST CRISIS (Adherence Killer)
- 31% quit due to cost
- $1,000/month list price
- Compounding pharmacies being shut down
- Most can't afford long-term use
- **Makes our "life after GLP-1" positioning essential**

### 5. SIDE EFFECTS (Quality of Life)
- 48% report severe nausea
- 29% experience mental health issues (mood swings, brain fog, anxiety)
- GI issues nearly universal
- Some require ER visits
- **Better management = better adherence**

---

## üé™ POSITIONING SHIFT

### ‚ùå OLD Positioning (Generic)
**"24/7 GLP-1 patient companion"**
- Sounds like medication optimization
- Doesn't address the discontinuation cliff
- Competes directly with telehealth prescribers
- Positions medication as the solution

### ‚úÖ NEW Positioning (Differentiated)
**"Insurance policy against weight regain after GLP-1s"**
- Addresses #1 user fear
- Reframes medication as temporary tool
- Differentiates from prescribers (they sell meds, we sell what happens after)
- Creates urgency (build foundation NOW while medicated)
- Acknowledges reality (most can't afford meds forever)

---

## üèóÔ∏è PRODUCT STRATEGY

### Mission Reframe
**OLD**: Support GLP-1 users during treatment
**NEW**: Turn temporary GLP-1 results into permanent transformations

### Success Metric Shift
**OLD**: Adherence while on medication
**NEW**: Weight maintenance 12 months AFTER stopping medication

### Product Priorities (Tiered)

#### üî¥ TIER 1: Existential (Must-Have)
**These prevent the disaster scenario**

1. **Muscle Preservation System**
   - Daily protein intake tracking (target: 0.5-0.9g/lb)
   - Resistance training protocol (2-3x/week minimum)
   - Muscle mass monitoring
   - Metabolic health score
   - **Why**: Prevents metabolism crash post-medication

2. **Habit Formation Engine**
   - Daily micro-behaviors that become automatic
   - Progressive complexity (start simple, build up)
   - Streak tracking & reinforcement
   - Context-specific triggers
   - **Why**: Habits persist after medication stops

3. **Transition Readiness System**
   - "Life after GLP-1" readiness score
   - Gradual dose reduction planning
   - Maintenance behavior certification
   - Psychological preparation
   - **Why**: Manages the terrifying moment of stopping

#### üü° TIER 2: Support (Critical for Experience)
**These improve adherence and prevent early dropout**

4. **Side Effect Management**
   - Nausea mitigation protocols
   - Food/symptom pattern recognition
   - Hydration & electrolyte guidance
   - Medical escalation triggers
   - **Why**: 48% report severe nausea; prevents discontinuation

5. **Daily Check-in System**
   - Morning intention setting
   - Evening reflection
   - Protein/hydration compliance
   - Symptom tracking
   - **Why**: Fills the medical support gap

6. **Medical Supervision Layer**
   - Physician review of concerning patterns
   - Dose adjustment recommendations
   - Red flag escalation
   - Clinical credibility
   - **Why**: 81% want prescriber-led care

#### üü¢ TIER 3: Enhancement (Nice-to-Have)
**These improve engagement but don't solve core problem**

7. **Data Insights**
   - Food/symptom correlations
   - Progress visualization
   - Predictive recommendations
   - **Why**: Users like data, but it's not the core value

8. **Community Support**
   - Peer accountability
   - Success stories
   - Expert AMAs
   - **Why**: Social proof, but not the differentiator

9. **Gamification**
   - Points, badges, levels
   - Competition elements
   - **Why**: Engagement boost, not core value

---

## üìà GO-TO-MARKET STRATEGY

### Target Audience Evolution

#### Phase 1: Early Adopters (Current)
- Already on GLP-1s
- Can afford $32/month
- Health-conscious, tech-savvy
- Concerned about side effects

#### Phase 2: Fear-Driven (6 months)
- Approaching 6-month mark on GLP-1s
- Starting to worry about stopping
- Experiencing cost pressure
- Noticing muscle loss
- **Messaging**: "Don't wait until you stop to wish you'd started building habits"

#### Phase 3: Post-Discontinuation (12 months)
- Already stopped GLP-1s
- Starting to regain weight
- Desperate for solutions
- **Messaging**: "It's not too late to rebuild"

### Messaging Framework

#### Problem Agitation
"You're losing weight. But are you building the foundation to keep it off? 70% of people regain the weight after stopping GLP-1s. The medication works ‚Äî but only while you're on it. And most people can't afford to take it forever."

#### Solution Positioning
"Zempi builds the metabolic foundation that outlasts the medication. Preserved muscle. Automatic habits. Clinical support. So when GLP-1s end, your results don't."

#### Proof Points
- Muscle preservation protocol based on clinical research
- Daily habit coaching for behavior automation
- Medical supervision throughout journey
- Designed for Brazil's WhatsApp-first culture
- R$32/month vs. R$3,000+ for medication alone

---

## üé® BRAND POSITIONING

### What We Are
- **Life-after-medication insurance**
- **Habit formation system with clinical guardrails**
- **The bridge from temporary medication to permanent transformation**
- **Daily accountability partner in your pocket**

### What We're NOT
- Not a medication prescriber (we complement, not compete)
- Not a nutrition/fitness app (we're medication-specific)
- Not a tracking tool (we're a coaching system)
- Not just for "during" GLP-1s (we're for "after")

### Competitive Differentiation

| Competitor Type | Their Focus | Zempi's Advantage |
|----------------|-------------|-------------------|
| Telehealth (Ro, Hims, etc.) | Prescribing medication | We solve what happens AFTER prescription |
| Generic coaching apps | General weight loss | GLP-1-specific protocols (muscle loss, side effects) |
| Tracking apps (MyFitnessPal) | Data logging | Active coaching + medical supervision |
| Doctors | Monthly check-ins | Daily support via WhatsApp |

---

## üî¨ CLINICAL FOUNDATION

### Evidence-Based Protocols

1. **Muscle Preservation**
   - Protein intake: 0.5-0.9g/lb body weight
   - Timing: 20-30g per meal for optimal synthesis
   - Resistance training: 2-3x/week minimum
   - Source: Clinical research on GLP-1 lean mass loss

2. **Side Effect Management**
   - Small, frequent meals
   - Bland, low-fat foods during nausea episodes
   - Hydration + electrolytes
   - Source: Patient community insights + clinical guidelines

3. **Transition Planning**
   - Gradual dose reduction
   - Habit certification milestones
   - Metabolic health markers
   - Source: Discontinuation studies showing regain patterns

### Medical Advisory Board
- Dr. Alexandre Almeida (current advisor)
- Need: Endocrinologist specializing in obesity medicine
- Need: Sports medicine specialist for muscle preservation
- Need: Behavioral psychologist for habit formation

---

## üí∞ BUSINESS MODEL EVOLUTION

### Current: Beta Launch
- R$32/month (launch pricing)
- WhatsApp-based coaching
- Basic feature set
- Goal: 100 users, validate core hypothesis

### Phase 2: Scale (6 months)
- R$49-69/month (standard pricing)
- Tiered offering:
  - **Basic**: AI + human review
  - **Premium**: Daily human coaching + medical review
  - **Enterprise**: Employer/insurance partnerships
- Goal: 1,000 users, unit economics proven

### Phase 3: Platform (12 months)
- Insurance partnerships (positioned as cost savings)
- Employer wellness programs
- Pharmacy channel partnerships
- White-label for healthcare systems
- Goal: 10,000+ users, revenue diversification

### Unit Economics Target
- CAC: R$150-200 (paid social, content, referral)
- LTV: R$800-1,200 (12-18 month retention)
- LTV:CAC ratio: 4-6x
- Key insight: Long retention because value increases AFTER medication stops

---

## üì± PRODUCT ROADMAP

### Q4 2025: Foundation
- [x] WhatsApp integration
- [x] Daily check-in system
- [x] Basic symptom tracking
- [ ] Muscle preservation protocol v1
- [ ] Habit formation system v1
- [ ] Medical review workflow

### Q1 2026: Intelligence
- [ ] AI pattern recognition (food/symptom correlations)
- [ ] Transition readiness scoring
- [ ] Personalized protein targets
- [ ] Resistance training program generator
- [ ] Automated medical escalation triggers

### Q2 2026: Scale
- [ ] Tiered pricing launch
- [ ] Community features
- [ ] Provider portal for doctors
- [ ] Insurance pilot programs
- [ ] Referral system

### Q3 2026: Innovation
- [ ] Predictive weight regain algorithms
- [ ] Metabolic health biomarker integration
- [ ] Employer wellness platform
- [ ] Clinical trial partnerships
- [ ] International expansion planning

---

## üéØ KEY METRICS

### North Star Metric
**Weight maintained 12 months after GLP-1 discontinuation**
- Industry baseline: 35% (65% regain)
- Zempi target: 70% (30% regain)
- This is the only metric that matters long-term

### Supporting Metrics

#### Engagement
- Daily check-in completion rate (target: >80%)
- Weekly WhatsApp interactions (target: 15+)
- Protein target achievement (target: >70% of days)

#### Clinical Outcomes
- Muscle mass preservation (target: <15% of total weight lost)
- Side effect severity score (target: -50% vs. baseline)
- GLP-1 adherence rate (target: >85% at 6 months)

#### Business Health
- Monthly churn (target: <5%)
- NPS (target: >50)
- Referral rate (target: >30%)
- CAC payback period (target: <4 months)

---

## üöÄ CRITICAL SUCCESS FACTORS

### What Must Be True
1. **Clinical credibility**: Users must trust medical advice
2. **Daily engagement**: Habits require consistency
3. **WhatsApp-first**: Platform fit for Brazil
4. **Muscle preservation proof**: Must show measurable results
5. **Long-term retention**: Value increases over time

### Biggest Risks
1. **Regulation**: Medical advice via AI/WhatsApp
2. **Competition**: Telehealth giants adding coaching
3. **Market education**: Users don't understand regain risk yet
4. **Unit economics**: Can we deliver quality at R$32-69/month?
5. **Clinical outcomes**: Can we prove 12-month weight maintenance?

### Mitigation Strategies
1. Medical supervision + licensed physicians
2. Differentiated positioning (after meds, not during)
3. Content marketing on weight regain statistics
4. AI for scale + human for critical moments
5. Clinical trial partnership (in progress)

---

## üìö RESEARCH INSIGHTS (October 2025)

### User Pain Points (Reddit, Facebook, Clinical Sources)

#### Top 5 Challenges
1. **Weight regain terror** (70% discontinue, 65% regain)
2. **Muscle loss** (25-40% of weight lost)
3. **Inadequate support** (29% feel under-supported)
4. **Cost crisis** (31% quit due to cost)
5. **Side effects** (48% severe nausea, 29% mental health)

#### What Users Wish They Knew
- Side effects are more severe than expected (33% underestimated)
- Don't under-eat (protein is critical)
- Hydration + electrolytes reduce nausea
- Cost and support matter for long-term success
- 81% want personalized, prescriber-led care

#### Competitive Landscape
- **Telehealth prescribers**: Ro, Hims, Brello (medication focus)
- **Coaching platforms**: Omada, Fridays (holistic wellness)
- **Tracking apps**: MyFitnessPal (data logging)
- **Gap**: No one focused on "life after GLP-1s"

---

## üéì STRATEGIC PRINCIPLES

### 1. Medication as Bridge, Not Destination
GLP-1s are temporary. Our job is to make the results permanent.

### 2. Build Foundation During, Not After
Waiting until discontinuation is too late. Habits must form while medicated.

### 3. Muscle is Metabolism
Preserving lean mass is the single biggest predictor of long-term success.

### 4. Daily Touchpoints Win
Behavior change requires consistency. WhatsApp enables this at scale.

### 5. Clinical Credibility is Non-Negotiable
Users are terrified of making mistakes. Medical oversight is the moat.

### 6. WhatsApp-First for Brazil
Platform fit = competitive advantage. Don't fight cultural defaults.

### 7. Long-Term Retention is the Business Model
Most subscriptions churn fast. Our value INCREASES when medication stops.

---

## üîÑ NEXT STEPS

### Immediate (This Week)
- [ ] Update website copy to reflect new positioning
- [ ] Revise hero section: "Insurance against weight regain"
- [ ] Update benefits to prioritize muscle preservation & habit formation
- [ ] Add "What happens after GLP-1s?" education section
- [ ] Refresh testimonials to emphasize long-term concerns

### Short-Term (This Month)
- [ ] Create content series on weight regain statistics
- [ ] Develop muscle preservation protocol documentation
- [ ] Launch transition readiness assessment
- [ ] Interview users about discontinuation fears
- [ ] Partner outreach to endocrinologists

### Medium-Term (Next Quarter)
- [ ] Clinical trial proposal for 12-month weight maintenance
- [ ] Insurance partnership pitch deck
- [ ] Employer wellness program framework
- [ ] Community features for peer support
- [ ] International expansion research (US, LATAM)

---

## üí° FINAL STRATEGIC INSIGHT

**The GLP-1 market is solving the wrong problem.**

Everyone is optimizing the medication journey. But the medication journey is temporary. The real problem is what happens AFTER.

Zempi is the only company positioning for the inevitable discontinuation that 70% of users will face. We're not better at medication management. We're solving a different problem entirely.

**That's the moat.**

---

## üìû CONTACT & APPROVAL
**Document Owner**: Lucas Coelho
**Last Review**: October 2025
**Next Review**: January 2026
**Status**: APPROVED - Ready for Implementation

---

*"The medication is temporary. Make the results permanent. That's the business."*
